Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Inflammation in atherosclerosis

Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315 · see citing works

Inflammation and Atherosclerosis

Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724 · see citing works

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene

Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631 · see citing works

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works

CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein

Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986 · see citing works

Atherosclerosis

Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,049 · see citing works

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024 · see citing works

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965 · see citing works

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574 · see citing works

Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 ( Tlr4 )

Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525 · see citing works

Toll-like receptors control activation of adaptive immune responses

Schnare, M., Barton, G. M., Czopik, A. K., Takeda, K., Akira, S., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,364 · see citing works

Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes

Kawai, T., Takeuchi, O., Fujita, T., Inoue, J., Mühlradt, P. F., Sato, S., Hoshino, K., & Akira, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5887 · Cited by 1,095 · see citing works

Toll-like Receptor 4 Polymorphisms and Atherogenesis

Kiechl, S. J., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024 · see citing works

Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,014 · see citing works

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.

Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · PubMed · Cited by 847 · see citing works

Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Zhang, G.-L., & Ghosh, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11837 · Cited by 842 · see citing works

Human Toll-Like Receptors Mediate Cellular Activation by <i>Mycobacterium tuberculosis</i>

Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804 · see citing works

Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748 · see citing works

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL

Binder, C. J., Hörkkö, S., Dewan, A. K., Chang, M.-K., Kieu, E., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., & Silverman, G. J. (2003) · Nature Medicine · doi:10.1038/nm876 · Cited by 735 · see citing works

NF-κB: pivotal mediator or innocent bystander in atherogenesis?

Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727 · see citing works

Expression of Toll-Like Receptors in Human Atherosclerotic Lesions

Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · Circulation · doi:10.1161/circ.105.10.1158 · Cited by 706 · see citing works

Mouse Models of Atherosclerosis

Breslow, J. L. (1996) · Science · doi:10.1126/science.272.5262.685 · Cited by 699 · see citing works

Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

Xu, X.-O. H., Shah, P. K., Faure, E., Equils, O., Thomas, L. S., Fishbein, M. C., Luthringer, D., Xu, X., Rajavashisth, T. B., Yano, J., et al. (2001) · Circulation · doi:10.1161/hc5001.100631 · Cited by 668 · see citing works

Innate and acquired immunity in atherogenesis

Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A. K., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642 · see citing works

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine · doi:10.1038/nm1008 · Cited by 634 · see citing works

Mechanisms of plaque vulnerability and rupture

Shah, P. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02834-6 · Cited by 541 · see citing works

The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

Davenport, P., & Tipping, P. G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 442 · see citing works

Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells

Miller, Y. I., Viriyakosol, S., Binder, C. J., Feramisco, J. R., Kirkland, T. N., & Witztum, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209634200 · Cited by 398 · see citing works

Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions

Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379 · see citing works

Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor–deficient mice

Kanters, E., Pasparakis, M., Gijbels, M. J., Vergouwe, M. N., Partouns-Hendriks, I., Fijneman, R. J. A., Clausen, B. E., Förster, I., Kockx, M. M., Rajewsky, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18580 · Cited by 340 · see citing works

The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice

Lee, T., Yen, H.-C., Pan, C., & Chau, L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 310 · see citing works

Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice

Burleigh, M. E., Babaev, V. R., Oates, J. A., Harris, R. C., Gautam, S., Riendeau, D., Marnett, L. J., Morrow, J. D., Fazio, S., & Linton, M. F. (2002) · Circulation · doi:10.1161/01.cir.0000014927.74465.7f · Cited by 277 · see citing works

Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor–deficient mice

Kanters, E., Pasparakis, M., Gijbels, M. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318580 · Cited by 272 · see citing works

Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences

Fredrikson, G. N., Söderberg, I., Lindholm, M., Dimayuga, P. C., Chyu, K., Shah, P. K., & Nilsson, J. Å. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067937.93716.db · Cited by 261 · see citing works

Murine TOLL-like Receptor 4 Confers Lipopolysaccharide Responsiveness as Determined by Activation of NFκB and Expression of the Inducible Cyclooxygenase

Rhee, S. H., & Hwang, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007386200 · Cited by 247 · see citing works

Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary Events

Ameziane, N., Beillat, T., Verpillat, P., Chollet‐Martin, S., Aumont, M.-C., Seknadji, P., Lamotte, M., Lebret, D., Ollivier, V., & de Prost, D. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000101191.92392.1d · Cited by 241 · see citing works

Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events

Boekholdt, S. M., Agema, W. R. P., Peters, R. J. G., Zwinderman, A. H., van der Wall, E. E., Reitsma, P. H., Kastelein, J. J. P., & Jukema, J. W. (2003) · Circulation · doi:10.1161/01.cir.0000068311.40161.28 · Cited by 224 · see citing works

Endotoxin can induce MyD88-deficient dendritic cells to support Th2 cell differentiation

Kaisho, T. (2002) · International Immunology · doi:10.1093/intimm/dxf039 · Cited by 197 · see citing works

Genetically Resistant Mice Lacking MyD88-Adapter Protein Display a High Susceptibility to Leishmania major Infection Associated with a Polarized Th2 Response

Muraille, É., Trez, C. D., Brait, M., BAETSELIER, P. D., Léo, O., & Carlier, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4237 · Cited by 193 · see citing works

Infectious Agents Are Not Necessary for Murine Atherogenesis

Wright, S. D., Burton, C., Hernandez, M., Hassing, H., Montenegro, J., Mundt, S., Patel, S., Card, D. J., Hermanowski-Vosatka, A., Bergstrom, J. D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1437 · Cited by 176 · see citing works

Receptors Involved in the Oxidized 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine-mediated Synthesis of Interleukin-8

Walton, K. A., Hsieh, X., Gharavi, N. M., Wang, S. V., Wang, G., Yeh, M. W., Cole, A. L., & Berliner, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300738200 · Cited by 169 · see citing works

Determinants of Atherosclerosis Susceptibility in the C3H and C57BL/6 Mouse Model

Shi, W., Wang, N. J., Shih, D. M., Sun, V. Z., Wang, X., & Lusis, A. J. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1078 · Cited by 138 · see citing works

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses

Bartfai, T., Behrens, M. M., Gaidarova, S., Pemberton, J., Shivanyuk, A. N., & REBEK, J. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932746100 · Cited by 132 · see citing works

Cyclooxygenase Isoforms and Platelet Vessel Wall Interactions in the Apolipoprotein E Knockout Mouse Model of Atherosclerosis

Belton, O., Duffy, A. M., Toomey, S., & Fitzgerald, D. J. (2003) · Circulation · doi:10.1161/01.cir.0000104565.78013.ad · Cited by 127 · see citing works

Toll-like receptors in cardiovascular diseases

DEKLEIJN, D., & Pasterkamp, G. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00348-1 · Cited by 116 · see citing works

Hematopoietic NF-κB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype

Kanters, E., Gijbels, M. J., van der Made, I., Vergouwe, M. N., Heeringa, P., Kraal, G., Hofker, M. H., & de Winther, M. P. J. (2003) · Blood · doi:10.1182/blood-2003-05-1450 · Cited by 111 · see citing works

Antibiotic Therapy After Acute Myocardial Infarction

Zahn, R., Schneider, S., Frilling, B., Seidl, K., Tebbe, U., Weber, M. A., Gottwik, M. G., Altmann, E., Seidel, F., Rox, J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000054613.57105.06 · Cited by 106 · see citing works

Chronic infection and coronary artery disease

Muhlestein, J. B., & Anderson, J. L. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00054-7 · Cited by 80 · see citing works

Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice

Rott, D., Zhu, J., Burnett, M. S., Zhou, Y., Zalles-Ganley, A., Ogunmakinwa, J., & Epstein, S. E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00304-8 · Cited by 79 · see citing works

Reduced Progression of Early Carotid Atherosclerosis After Antibiotic Treatment and Chlamydia pneumoniae Seropositivity

Sander, D., Winbeck, K., Klingelhöfer, J., Etgen, T., & Conrad, B. (2002) · Circulation · doi:10.1161/01.cir.0000036748.26775.8d · Cited by 77 · see citing works

Antibiotic Treatment of Atherosclerotic Cardiovascular Disease

Grayston, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000056032.56396.89 · Cited by 72 · see citing works

Cyclooxygenase-2 Blockade Does Not Impair Endothelial Vasodilator Function in Healthy Volunteers

Verma, S., Raj, S. R., Shewchuk, L., Mather, K. J., & Anderson, T. J. (2001) · Circulation · doi:10.1161/hc4901.101350 · Cited by 70 · see citing works

The Mechanisms by Which Infectious Agents May Contribute to Atherosclerosis and Its Clinical Manifestations

Kol, A., & Libby, P. (1998) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(98)00010-3 · Cited by 69 · see citing works

Toll-like receptor 4 and atherogenesis

Kiechl, S. J., Wiedermann, C. J., & Willeit, J. (2003) · Annals of Medicine · doi:10.1080/07853890310008215 · Cited by 58 · see citing works

Vaccination Against Atherosclerosis

Hansson, G. K. (2002) · Circulation · doi:10.1161/01.cir.0000035275.64667.a3 · Cited by 57 · see citing works

No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice

Olesen, M., Kwong, E. C., Meztli, A., Kontny, F. P., Seljeflot, I., Arnesen, H., Lyngdorf, L. G., & Falk, E. (2002) · Scandinavian Cardiovascular Journal · doi:10.1080/140174302762659094 · Cited by 47 · see citing works

Progression of Early Carotid Atherosclerosis Is Only Temporarily Reduced After Antibiotic Treatment of Chlamydia pneumoniae Seropositivity

Sander, D., Winbeck, K., Klingelhöfer, J., Etgen, T., & Conrad, B. (2004) · Circulation · doi:10.1161/01.cir.0000117232.30832.ec · Cited by 46 · see citing works

Toll-like receptors in innate immunity

Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328 · see citing works

Sterile inflammation: sensing and reacting to damage

Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · see citing works

Macrophages in atherosclerosis: a dynamic balance

Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559 · see citing works

The immune system in atherosclerosis

Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,331 · see citing works

The immune response in atherosclerosis: a double-edged sword

Hansson, G. K., & Libby, P. (2006) · Nature reviews. Immunology · doi:10.1038/nri1882 · Cited by 2,176 · see citing works

Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways

Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701 · see citing works

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · see citing works

Negative regulation of Toll-like receptor-mediated immune responses

Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · see citing works

Immune and Inflammatory Mechanisms of Atherosclerosis

Galkina, E., & Ley, K. F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,446 · see citing works

Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury

Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356 · see citing works

Atherosclerotic Plaque Progression and Vulnerability to Rupture

Virmani, R., Kolodgie, F. D., BURKE, A. P., Finn, A. V., Gold, H. K., Tulenko, T. N., Wrenn, S. P., & Narula, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000178991.71605.18 · Cited by 1,326 · see citing works

Human oral, gut, and plaque microbiota in patients with atherosclerosis

Koren, O., Spor, A., Felin, J., Fåk, F., Stombaugh, J., Tremaroli, V., Behre, C. J., Knight, R., Fagerberg, B., Ley, R. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011383107 · Cited by 1,196 · see citing works

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183 · see citing works

Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes

Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180 · see citing works

Dietary lipids, gut microbiota and lipid metabolism

Schoeler, M., & Caesar, R. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09512-0 · Cited by 1,163 · see citing works

INFLAMMATION AND ATHEROSCLEROSIS

Hansson, G. K., Robertson, A.-K. L., & Söderberg‐Nauclér, C. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100100 · Cited by 1,049 · see citing works

Nutrient sensing and inflammation in metabolic diseases

Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040 · see citing works

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039 · see citing works

The role of the gut microbiota in energy metabolism and metabolic disease

Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · see citing works

Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling

Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.026 · Cited by 960 · see citing works

Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer

Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 938 · see citing works

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926 · see citing works

Obesity, inflammation, and the gut microbiota

Cox, A. J., West, N. P., & Cripps, A. W. (2015) · The Lancet Diabetes &amp; Endocrinology · doi:10.1016/s2213-8587(14)70134-2 · Cited by 869 · see citing works

Scavenger receptors in homeostasis and immunity

Canton, J., Neculai, D., & Grinstein, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3515 · Cited by 838 · see citing works

Inflammation and plaque vulnerability

Hansson, G. K., Libby, P., & Tabas, I. A. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 809 · see citing works

Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages

Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251608.09329.9a · Cited by 806 · see citing works

A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation.

Erridge, C., Attina, T., Spickett, C. M., & Webb, D. J. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1286 · Cited by 776 · see citing works

NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases

Abderrazak, A., Syrovets, T., Couchie, D., Hadri, K. E., Friguet, B., Simmet, T., & Rouis, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.008 · Cited by 737 · see citing works

Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?

Rehman, K., & Akash, M. S. H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0303-y · Cited by 685 · see citing works

Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans

Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 667 · see citing works

Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity

Miller, Y. I., Choi, S.-H., Wiesner, P., Fang, L., Harkewicz, R., Hartvigsen, K., Boullier, A., Gonen, A., Diehl, C. J., Que, X., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.223875 · Cited by 654 · see citing works

Role of gut microbiota in atherosclerosis

Jonsson, A. L., & Bäckhed, F. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.183 · Cited by 647 · see citing works

Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease

Schröder, N. W. J., & Schumann, R. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01308-3 · Cited by 638 · see citing works

Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells

Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619 · see citing works

Regulated Accumulation of Desmosterol Integrates Macrophage Lipid Metabolism and Inflammatory Responses

Spann, N. J., Garmire, L. X., McDonald, J. G., Myers, D. S., Milne, S. B., Shibata, N., Reichart, D. R., Fox, J. N., Shaked, I., Heudobler, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.054 · Cited by 605 · see citing works

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics

Depuydt, M. A. C., Prange, K. H. M., Slenders, L., Örd, T., Elbersen, D., Boltjes, A., de Jager, S. C. A., Asselbergs, F. W., de Borst, G. J., Aavik, E., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316770 · Cited by 591 · see citing works

Nuclear Factor κB Signaling in Atherogenesis

de Winther, M. P. J., Kanters, E., Kraal, G., & Hofker, M. H. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160340.72641.87 · Cited by 586 · see citing works

Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity

Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., & Schwartz, M. W. (2007) · Circulation Research · doi:10.1161/circresaha.106.142851 · Cited by 584 · see citing works

Recent Advances on the Role of Cytokines in Atherosclerosis

Ait‐Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207415 · Cited by 578 · see citing works

Scavenger Receptors in Atherosclerosis: Beyond Lipid Uptake

Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562 · see citing works

Fatty Acids Modulate Toll-like Receptor 4 Activation through Regulation of Receptor Dimerization and Recruitment into Lipid Rafts in a Reactive Oxygen Species-dependent Manner

Wong, S. W., Kwon, M.-J., Choi, A. M. K., Kim, H.-P., Nakahira, K., & Hwang, D. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044065 · Cited by 562 · see citing works

Monocyte and Macrophage Dynamics During Atherogenesis

Ley, K. F., Miller, Y. I., & Hedrick, C. C. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221127 · Cited by 554 · see citing works

Modulation of atherosclerosis in mice by Toll-like receptor 2

Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549 · see citing works

MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages

Nazari-Jahantigh, M., Wei, Y., Noels, H., Akhtar, S., Zhou, Z., Koenen, R. R., Heyll, K., Gremse, F., Kiessling, F. M., Grommes, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61716 · Cited by 529 · see citing works

Inflammation and its Resolution as Determinants of Acute Coronary Syndromes

Libby, P., Tabas, I. A., Fredman, G., & Fisher, E. A. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302699 · Cited by 523 · see citing works

Translating molecular discoveries into new therapies for atherosclerosis

Rader, D. J., & Daugherty, A. (2008) · Nature · doi:10.1038/nature06796 · Cited by 515 · see citing works

Signalling networks regulating cyclooxygenase-2

Tsatsanis, C., Androulidaki, A., Venihaki, M., & Margioris, A. N. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.021 · Cited by 493 · see citing works

The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology

Vereecke, L., Beyaert, R., & Loo, G. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.007 · Cited by 483 · see citing works

Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress

Seimon, T. A., Nadolski, M. J., Liao, X., Magallon, J., Nguyen, M. T., Feric, N. T., Koschinsky, M. L., Harkewicz, R., Witztum, J. L., Tsimikas, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.010 · Cited by 478 · see citing works

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3

Nardo, D. D., Labzin, L. I., Kono, H., Seki, R., Schmidt, S. V., Beyer, M., Xu, D., Zimmer, S., Lahrmann, C., Schildberg, F. A., et al. (2013) · Nature Immunology · doi:10.1038/ni.2784 · Cited by 463 · see citing works

Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages

Yvan‐Charvet, L., Welch, C. L., Pagler, T. A., Ranalletta, M., Lamkanfi, M., Han, S., Ishibashi, M., Li, R., Wang, N., & Tall, A. R. (2008) · Circulation · doi:10.1161/circulationaha.108.793869 · Cited by 456 · see citing works

Molecular Biology of Atherosclerosis

Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 456 · see citing works

Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?

Engelen, S. E., Robinson, A., Zurke, Y.-X., & Monaco, C. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00668-4 · Cited by 442 · see citing works

Microbial modulation of cardiovascular disease

Brown, J. M., & Hazen, S. L. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.149 · Cited by 440 · see citing works

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes

Dasu, M. R. K., Devaraj, S., Zhao, L., Hwang, D. H., & Jialal, I. (2008) · Diabetes · doi:10.2337/db08-0564 · Cited by 436 · see citing works

“ <i>Gum Bug, Leave My Heart Alone</i> !”—Epidemiologic and Mechanistic Evidence Linking Periodontal Infections and Atherosclerosis

Kebschull, M., Demmer, R. T., & Papapanou, P. N. (2010) · Journal of Dental Research · doi:10.1177/0022034510375281 · Cited by 429 · see citing works

NLRP3 inflammasomes link inflammation and metabolic disease

De Nardo, D., & Latz, E. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.004 · Cited by 425 · see citing works

Macrophages Generate Reactive Oxygen Species in Response to Minimally Oxidized Low-Density Lipoprotein

Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S. A., Almazan, F., Witztum, J. L., & Miller, Y. I. (2008) · Circulation Research · doi:10.1161/circresaha.108.181040 · Cited by 423 · see citing works

Innate sensing of oxidation-specific epitopes in health and disease

Binder, C. J., Papac-Milicevic, N., & Witztum, J. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.63 · Cited by 403 · see citing works

TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease

Yang, J., Wise, L., & Fukuchi, K.-I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00724 · Cited by 387 · see citing works

Toll‐like receptors, endogenous ligands, and systemic autoimmune disease

Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. A., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 384 · see citing works

Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease

Violi, F., Cammisotto, V., Bartimoccia, S., Pignatelli, P., Carnevale, R., & Nocella, C. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00737-2 · Cited by 384 · see citing works

Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways

Koushki, K., Shahbaz, S. K., Mashayekhi, K., Sadeghi, M., Zayeri, Z. D., Taba, M. Y., Banach, M., Al-Rasadi, K., Johnston, T. P., & Sahebkar, A. (2021) · Clinical Reviews in Allergy &amp; Immunology · doi:10.1007/s12016-020-08791-9 · Cited by 382 · see citing works

Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis

Gareus, R., Kotsaki, E., Xanthoulea, S., van der Made, I., Gijbels, M. J., Kardakaris, R., Polykratis, A., Kollias, G. A., de Winther, M. P. J., & Pasparakis, M. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.016 · Cited by 382 · see citing works

TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion

Quillard, T., Araújo, H. A., Franck, G., Shvartz, E., Sukhova, G. K., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv044 · Cited by 382 · see citing works

Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State

Devaraj, S., Dasu, M. R. K., Rockwood, J., Winter, W. E., Griffen, S. C., & Jialal, I. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2185 · Cited by 374 · see citing works

The Emerging Role of Innate Immunity in the Heart and Vascular System

Mann, D. L. (2011) · Circulation Research · doi:10.1161/circresaha.110.226936 · Cited by 360 · see citing works

Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics

Gao, W., Xiong, Y., Li, Q., & Yang, H. Y. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00508 · Cited by 352 · see citing works

Integration of B cell responses through Toll-like receptors and antigen receptors

Rawlings, D. J., Schwartz, M. A., Jackson, S. W., & Meyer‐Bahlburg, A. (2012) · Nature reviews. Immunology · doi:10.1038/nri3190 · Cited by 337 · see citing works

Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol

Zhu, X., Owen, J. S., Wilson, M. D., Li, H., Griffiths, G. L., Thomas, M. J., Hiltbold, E. M., Fessler, M. B., & Parks, J. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006486 · Cited by 331 · see citing works

Mechanisms of Disease: Toll-like receptors in cardiovascular disease

Frantz, S., Ertl, G., & Bauersachs, J. K. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0938 · Cited by 314 · see citing works

TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain

Kawamoto, T., Ii, M., Kitazaki, T., Iizawa, Y., & Kimura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.026 · Cited by 311 · see citing works

New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway

Tang, Z.-H., Peng, J., Ren, Z., Yang, J., Li, T.-T., Li, T.-H., Wang, Z., Wei, D.-H., Liu, L.-S., Zheng, X.-L., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.04.023 · Cited by 291 · see citing works

Toll-Like Receptor 4–Dependent and –Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages

Miller, Y. I., Viriyakosol, S., Worrall, D. S., Boullier, A., Butler, S. S., & Witztum, J. L. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000159891.73193.31 · Cited by 279 · see citing works

S100A8 and S100A9: DAMPs at the Crossroads between Innate Immunity, Traditional Risk Factors, and Cardiovascular Disease

Șchiopu, A., & Cotoi, O. S. (2013) · Mediators of Inflammation · doi:10.1155/2013/828354 · Cited by 269 · see citing works

Specific Inhibition of MyD88-Independent Signaling Pathways of TLR3 and TLR4 by Resveratrol: Molecular Targets Are TBK1 and RIP1 in TRIF Complex

Youn, H. S., Lee, J. Y., Fitzgerald, K. A., Young, H. A., Akira, S., & Hwang, D. H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3339 · Cited by 268 · see citing works

Platelets in atherosclerosis

von Hundelshausen, P., & Lievens, D. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0592 · Cited by 268 · see citing works

Mechanisms That Regulate Macrophage Burden in Atherosclerosis

Randolph, G. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.301174 · Cited by 265 · see citing works

Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in <i>Jak2</i> ^<i>V617F</i> Mice

Wang, W., Liu, W., Fidler, T., Wang, Y., Tang, Y., Woods, B., Welch, C., Cai, B., Silvestre-Roig, C., Ai, D., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313283 · Cited by 262 · see citing works

Vascular Lipid Accumulation, Lipoprotein Oxidation, and Macrophage Lipid Uptake in Hypercholesterolemic Zebrafish

Stoletov, K. V., Fang, L., Choi, S.-H., Hartvigsen, K., Hansen, L. F., Hall, C. J., Pattison, J., Juliano, J., Miller, E. R., Almazan, F., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.189803 · Cited by 261 · see citing works

Toll-like Receptors in the Vascular System: Sensing the Dangers Within

Goulopoulou, S., McCarthy, C. G., & Webb, R. C. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010090 · Cited by 261 · see citing works

MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4

Yang, K., He, Y. S., Wang, X. Q., Lu, L., Chen, Q., Liu, J., Sun, Z., & Shen, W. F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.02.009 · Cited by 258 · see citing works

Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling

Erridge, C., & Samani, N. J. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194050 · Cited by 258 · see citing works

Innate immunity, macrophage activation, and atherosclerosis

Yan, Z., & Hansson, G. K. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00554.x · Cited by 254 · see citing works

Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism

Caesar, R., Fåk, F., & Bäckhed, F. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02270.x · Cited by 253 · see citing works

TLR4 and Insulin Resistance

Kim, J. J., & Sears, D. D. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/212563 · Cited by 249 · see citing works

Mechanisms of triglyceride accumulation in activated macrophages

Feingold, K. R., Shigenaga, J. K., Kazemi, M. R., McDonald, C. M., Patzek, S. M., Cross, A. S., Moser, A. H., & Grünfeld, C. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111537 · Cited by 249 · see citing works

Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome

Fessler, M. B., Rudel, L. L., & Brown, J. M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832fa5c4 · Cited by 248 · see citing works

The role of Toll-like receptors in chronic inflammation

Drexler, S. K., & Foxwell, B. M. J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.009 · Cited by 248 · see citing works

Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses

Bonta, P. I., van Tiel, C. M., Vos, M., Pols, T. W. H., van Thienen, J. V., Ferreira, V., Arkenbout, E. K., Seppen, J., Spek, C. A., van der Poll, T., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000238346.84458.5d · Cited by 248 · see citing works

REVIEW: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways

Hayashi, C., Gudino, C. V., Gibson III, F. C., & Genco, C. A. (2010) · Molecular Oral Microbiology · doi:10.1111/j.2041-1014.2010.00582.x · Cited by 244 · see citing works

Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib

Yvan‐Charvet, L., Kling, J., Pagler, T. A., Li, H., Hubbard, B. K., Fisher, T., Sparrow, C. P., Taggart, A. K. P., & Tall, A. R. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207142 · Cited by 238 · see citing works

Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake

Choi, S.-H., Harkewicz, R., Lee, J. H., Boullier, A., Almazan, F., Li, A. C., Witztum, J. L., Bae, Y. S., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.192880 · Cited by 227 · see citing works

Emerging role of Toll-like receptors in atherosclerosis

Curtiss, L. K., & Tobias, P. S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800056-jlr200 · Cited by 225 · see citing works

Mammalian Toll-like receptors: to immunity and beyond

Hopkins, P. A., & Sriskandan, S. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02801.x · Cited by 220 · see citing works

S100A8 and S100A9 in Cardiovascular Biology and Disease

Averill, M. M., Kerkhoff, C., & Bornfeldt, K. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.236927 · Cited by 219 · see citing works

Inducible Toll‐like Receptor and NF‐κB Regulatory Pathway Expression in Human Adipose Tissue

Vitseva, O. I., Tanrıverdi, K., Tchkonia, T., Kirkland, J. L., McDonnell, M. E., Apovian, C. M., Freedman, J. E., & Gokce, N. (2008) · Obesity · doi:10.1038/oby.2008.25 · Cited by 215 · see citing works

Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk

Neves, A. L., Coelho, J., Couto, L., Leite-Moreira, A., & Roncon-Albuquerque, R. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0079 · Cited by 211 · see citing works

TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis

Michelsen, K. S., Doherty, T. M., Shah, P. K., & Arditi, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5901 · Cited by 211 · see citing works

Apolipoprotein E Enhances MicroRNA-146a in Monocytes and Macrophages to Suppress Nuclear Factor-κB–Driven Inflammation and Atherosclerosis

Li, K., Ching, D., Luk, F. S., & Raffaı̈, R. L. (2015) · Circulation Research · doi:10.1161/circresaha.117.305844 · Cited by 210 · see citing works

Protective Role for Toll-Like Receptor-9 in the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice

Koulis, C., Chen, Y., Hausding, C., Ahrens, I., Kyaw, T. S., Tay, C., Allen, T. J., Jandeleit-Dahm, K. A. M., Sweet, M. J., Akira, S., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302407 · Cited by 80 · see citing works

Platelet Factor 4 and Toll-Like Receptor 2 are Expressed in Atherosclerotic Plaques of Apolipoprotein E~(-/-)Mice

Hai, J. (2007) · Chinese Journal of Arteriosclerosis

Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis

Chen, S., Shimada, K., Crother, T. R., Erbay, E., Shah, P. K., & Arditi, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.072 · Cited by 32 · see citing works

Toll-like receptor signaling and atherosclerosis

Michelsen, K. S., & Arditi, M. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219662.88409.7c · Cited by 41 · see citing works

Role of Toll-Like Receptor 4 in Intimal Foam Cell Accumulation in Apolipoprotein E–Deficient Mice

Higashimori, M., Tatro, J. B., Moore, K. J., Mendelsohn, M. E., Galper, J., & Beasley, D. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.210971 · Cited by 125 · see citing works